Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
BNIGF
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
globenewswire.comPOSITIVO
Beroni Group’s Enhanced COVID-19 Antigen Rapid Test Kit Received CE Certification
NEW YORK and SYDNEY, June 01, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, announced that it has received notification from its European Authorized Representati…
Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors
Beroni Group Limited NEW YORK and SYDNEY, Australia, March 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research,…
Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors
NEW YORK and SYDNEY, Australia, March 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovat…
Beroni Group to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
NEW YORK and SYDNEY, Australia, March 23, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovat…
Beroni Group Sets Up a New R&D Centre in High-Tech Hub in Zhuhai, China
NEW YORK and SYDNEY, Australia, Jan. 31, 2022 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovati…
Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits from Japan
NEW YORK and SYDNEY, Australia, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovati…
Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal
NEW YORK and SYDNEY, Australia, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based biopharmaceutical enterprise, today announced that its article entitled “Crystal struct…
Beroni Group Received Approval for 43.5% R&D Rebate from Australian Government for the Novel, Potential Anti-Cancer Drug PENAO
NEW YORK and SYDNEY, Australia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, today announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti…
Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO
NEW YORK and SYDNEY, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise, announced that PENAO Pty Ltd, its majority-owned, Sydney-based…
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit
NEW YORK and SYDNEY, Australia, April 27, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today announced that it has received the noti…
Beroni Acquires Majority Interest in PENAO, an Anti-Cancer Drug Development Company
NEW YORK and SYDNEY, Australia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise today announces that it has completed its majority acquisition…
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification
NEW YORK and SYDNEY, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovation and comm…
Beroni Group Launches a New Probiotics Health Product in China
NEW YORK and SYDNEY, Australia, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the research, development, innovati…
Beroni Group Named as a Top Infection Control Solutions Company in APAC for 2020
NEW YORK and SYDNEY, Australia, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise announced today that the Company has been reco…
Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19
NEW YORK and SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise, today announces successful completion of SARS…
Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19
NEW YORK and SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise, today announces successful completion of SARS…
Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19
NEW YORK and SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise, today announces successful completion of SARS…
Beroni Group Receives First Commercial Order for its COVID-19 Test Kits from Japan
NEW YORK and SYDNEY, Australia, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovatio…
Beroni Group Signs Agreement with Genscript Biotech Corporation to Conduct Further Study to Develop Nanobody-based Medical Solution for COVID-19
NEW YORK and SYDNEY, Australia, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), is pleased to announce that further to its announcement on August 4, 2020 regarding the development of a m…
Beroni Group Has Successfully Constructed and Purified 24 Types of Nanobodies for Detection and Treatment of COVID-19
NEW YORK and SYDNEY, Australia, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…
Beroni Group to Supply COVID-19 Antibody Test Kit to Japan
NEW YORK and SYDNEY, Australia, July 10, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…
Dr Richard Buchta Appointed as Director of Beroni Group
NEW YORK and SYDNEY, Australia, June 30, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…
Beroni Group Issues US$2.97 million of Convertible Notes to Fund Growth Plans
NEW YORK and SYDNEY, Australia, May 27, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…
Beroni Group R&D Team Identifies 24 Types of Nanobodies for Rapid Detection and Treatment of Coronavirus (COVID-19)
- Granted Approval by China Ministry of Commerce to Export Detection Kits Globally - - Obtained CE Certification by European Union - NEW YORK and SYDNEY, Australia, May 08, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“B…
Beroni Group’s SARS-CoV-2 IgG/IgM Antibody Detection Kit Received CE Certification
NEW YORK and SYDNEY, Australia, April 03, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovatio…
Beroni Group Included in List of Commercial Manufacturers and Laboratories Who Have Notified US FDA of Validated Serology Tests for COVID-19
NEW YORK and SYDNEY, Australia, April 03, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovatio…
Beroni Group Announces Submission of Emergency Use Authorization to US FDA for its COVID-19 Rapid Test Detection Kit
NEW YORK and SYDNEY, Australia, March 26, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovatio…
Beroni Group Advances Research and Development of Medical Solution for Coronavirus (COVID-19)
- Cytological Experiments Commenced in March 2020 - - Clinical Trials to Commence in April 2020 - NEW YORK and SYDNEY, Australia, March 09, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an inte…
Beroni Group Featured in New Research Initiation Report
NEW YORK and SYDNEY, Australia, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…
Beroni Group Announces Webcast from Biotech Showcase™ 2020 in San Francisco, USA
NEW YORK and SYDNEY, Australia, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…
Beroni Group to Present at Biotech Showcase™ 2020 in San Francisco, USA
NEW YORK and SYDNEY, Australia, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused on the research, development, innovation…
Beroni Group to Hold the Third Precision Medicine & Medical Care and Aging International Forum (with Conference Theme “Innovation Driving Development, Technology Leading Future”) in Tianjin, China on December 7-8, 2019
NEW YORK and SYDNEY, Australia, Nov. 05, 2019 (GLOBE NEWSWIRE) -- Beroni Group Limited (NSX: BTG; OTCQX: BNIGF) is pleased to announce that it will be holding the Third Precision Medicine & Medical Care and Aging International Forum (“Foru…
Beroni Group to Launch its Advanced US FDA-Approved Virus Diagnostic Kit to Help Combat Global Outbreaks of Zika, Dengue, Chikungunya and West Nile Viruses
NEW YORK and SYDNEY, Australia, Oct. 24, 2019 (GLOBE NEWSWIRE) -- In April 2019, Beroni Group Limited (“Beroni” or the “Company”) (NSX: BTG; OTCQX: BNIGF) signed an exclusive license agreement with Columbia University whereby Columbia Univ…
Beroni USA is Ready to Commercialise a Diagnostic Kit for Detecting Zika, Dengue, Chikungunya and West Nile Viruses Worldwide
NEW YORK and SYDNEY, Australia, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Beroni Group Limited (“Beroni’ or the “Company”) entered into an agreement with the Columbia University, New York (“Columbia University”) in March 2018 to provide US$1 mill…
Beroni Group Launches its First-Ever Japan-Made Stem Cell Based Regenerative Skincare Products in the Rapidly Growing Chinese Consumer Market
NEW YORK and SYDNEY, Australia, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Beroni Group Limited (NSX: BTG) (OTCQX: BNIGF) (“Company”) is pleased to announce that after five months of filing the registration, it has now secured the approval of Chin…
Beroni Group Expands Into Strategic Relationship With Jinshui Science & Education Park In Zhengzhou, China
PLACEHOLDER, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Beroni Group Limited (NSX: BTG)(OTCQX: BNIGF) (“Beroni” or the “Company”) and Zhengzhou Jinshui Science & Education Park (“Jinshui Park”) have signed a strategic cooperation agreement to join…